Report Detail
Global Substance Use Disorders (SUDs) Treatment Market Size, Status and Forecast 2019-2025
- RnM3123536 |
- 14 March, 2019 |
- Global |
- 90 Pages |
- QYResearch |
- Other
A substance use disorder (SUD), also known as a drug use disorder, is a medical condition in which the use of one or more substances leads to a clinically significant impairment or distress. Theres is habitually, dependence of an individual on any drugs, which turns into an addiction. Opioid, alcohol, tobacco and cigarettes are some of the common, drugs which has been misused leading to drugs addictions. In recent past, many products have been launched in market for treatment and management of SUD. Some commonly used drug for treatment of SUD are Disulfiram, Acamprosate, Naltrexone, Nicotine Replacement Treatment, Methadone, and Buprenorphine.
In 2018, the global Substance Use Disorders (SUDs) Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Substance Use Disorders (SUDs) Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Substance Use Disorders (SUDs) Treatment development in United States, Europe and China.
The key players covered in this study
Indivior
Pfizer
Alkermes
Novartis
Mylan
Cipla
Glenmark
Dr. Reddy's Laboratories
Teva Pharmaceutical
Market segment by Type, the product can be split into
Opioid Addiction
Tobacco/Nicotine Addiction
Alcohol Dependence
Market segment by Application, split into
Hospital & Clinics
Residential (non-hospital)
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Substance Use Disorders (SUDs) Treatment status, future forecast, growth opportunity, key market and key players.
To present the Substance Use Disorders (SUDs) Treatment development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Substance Use Disorders (SUDs) Treatment are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Key Market Segments
- 1.3 Players Covered
- 1.4 Market Analysis by Type
- 1.4.1 Global Substance Use Disorders (SUDs) Treatment Market Size Growth Rate by Type (2014-2025)
- 1.4.2 Opioid Addiction
- 1.4.3 Tobacco/Nicotine Addiction
- 1.4.4 Alcohol Dependence
- 1.5 Market by Application
- 1.5.1 Global Substance Use Disorders (SUDs) Treatment Market Share by Application (2014-2025)
- 1.5.2 Hospital & Clinics
- 1.5.3 Residential (non-hospital)
- 1.6 Study Objectives
- 1.7 Years Considered
2 Global Growth Trends
- 2.1 Substance Use Disorders (SUDs) Treatment Market Size
- 2.2 Substance Use Disorders (SUDs) Treatment Growth Trends by Regions
- 2.2.1 Substance Use Disorders (SUDs) Treatment Market Size by Regions (2014-2025)
- 2.2.2 Substance Use Disorders (SUDs) Treatment Market Share by Regions (2014-2019)
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
- 2.3.3 Market Opportunities
3 Market Share by Key Players
- 3.1 Substance Use Disorders (SUDs) Treatment Market Size by Manufacturers
- 3.1.1 Global Substance Use Disorders (SUDs) Treatment Revenue by Manufacturers (2014-2019)
- 3.1.2 Global Substance Use Disorders (SUDs) Treatment Revenue Market Share by Manufacturers (2014-2019)
- 3.1.3 Global Substance Use Disorders (SUDs) Treatment Market Concentration Ratio (CR5 and HHI)
- 3.2 Substance Use Disorders (SUDs) Treatment Key Players Head office and Area Served
- 3.3 Key Players Substance Use Disorders (SUDs) Treatment Product/Solution/Service
- 3.4 Date of Enter into Substance Use Disorders (SUDs) Treatment Market
- 3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
- 4.1 Global Substance Use Disorders (SUDs) Treatment Market Size by Type (2014-2019)
- 4.2 Global Substance Use Disorders (SUDs) Treatment Market Size by Application (2014-2019)
5 United States
- 5.1 United States Substance Use Disorders (SUDs) Treatment Market Size (2014-2019)
- 5.2 Substance Use Disorders (SUDs) Treatment Key Players in United States
- 5.3 United States Substance Use Disorders (SUDs) Treatment Market Size by Type
- 5.4 United States Substance Use Disorders (SUDs) Treatment Market Size by Application
6 Europe
- 6.1 Europe Substance Use Disorders (SUDs) Treatment Market Size (2014-2019)
- 6.2 Substance Use Disorders (SUDs) Treatment Key Players in Europe
- 6.3 Europe Substance Use Disorders (SUDs) Treatment Market Size by Type
- 6.4 Europe Substance Use Disorders (SUDs) Treatment Market Size by Application
7 China
- 7.1 China Substance Use Disorders (SUDs) Treatment Market Size (2014-2019)
- 7.2 Substance Use Disorders (SUDs) Treatment Key Players in China
- 7.3 China Substance Use Disorders (SUDs) Treatment Market Size by Type
- 7.4 China Substance Use Disorders (SUDs) Treatment Market Size by Application
8 Japan
- 8.1 Japan Substance Use Disorders (SUDs) Treatment Market Size (2014-2019)
- 8.2 Substance Use Disorders (SUDs) Treatment Key Players in Japan
- 8.3 Japan Substance Use Disorders (SUDs) Treatment Market Size by Type
- 8.4 Japan Substance Use Disorders (SUDs) Treatment Market Size by Application
9 Southeast Asia
- 9.1 Southeast Asia Substance Use Disorders (SUDs) Treatment Market Size (2014-2019)
- 9.2 Substance Use Disorders (SUDs) Treatment Key Players in Southeast Asia
- 9.3 Southeast Asia Substance Use Disorders (SUDs) Treatment Market Size by Type
- 9.4 Southeast Asia Substance Use Disorders (SUDs) Treatment Market Size by Application
10 India
- 10.1 India Substance Use Disorders (SUDs) Treatment Market Size (2014-2019)
- 10.2 Substance Use Disorders (SUDs) Treatment Key Players in India
- 10.3 India Substance Use Disorders (SUDs) Treatment Market Size by Type
- 10.4 India Substance Use Disorders (SUDs) Treatment Market Size by Application
11 Central & South America
- 11.1 Central & South America Substance Use Disorders (SUDs) Treatment Market Size (2014-2019)
- 11.2 Substance Use Disorders (SUDs) Treatment Key Players in Central & South America
- 11.3 Central & South America Substance Use Disorders (SUDs) Treatment Market Size by Type
- 11.4 Central & South America Substance Use Disorders (SUDs) Treatment Market Size by Application
12 International Players Profiles
- 12.1 Indivior
- 12.1.1 Indivior Company Details
- 12.1.2 Company Description and Business Overview
- 12.1.3 Substance Use Disorders (SUDs) Treatment Introduction
- 12.1.4 Indivior Revenue in Substance Use Disorders (SUDs) Treatment Business (2014-2019)
- 12.1.5 Indivior Recent Development
- 12.2 Pfizer
- 12.2.1 Pfizer Company Details
- 12.2.2 Company Description and Business Overview
- 12.2.3 Substance Use Disorders (SUDs) Treatment Introduction
- 12.2.4 Pfizer Revenue in Substance Use Disorders (SUDs) Treatment Business (2014-2019)
- 12.2.5 Pfizer Recent Development
- 12.3 Alkermes
- 12.3.1 Alkermes Company Details
- 12.3.2 Company Description and Business Overview
- 12.3.3 Substance Use Disorders (SUDs) Treatment Introduction
- 12.3.4 Alkermes Revenue in Substance Use Disorders (SUDs) Treatment Business (2014-2019)
- 12.3.5 Alkermes Recent Development
- 12.4 Novartis
- 12.4.1 Novartis Company Details
- 12.4.2 Company Description and Business Overview
- 12.4.3 Substance Use Disorders (SUDs) Treatment Introduction
- 12.4.4 Novartis Revenue in Substance Use Disorders (SUDs) Treatment Business (2014-2019)
- 12.4.5 Novartis Recent Development
- 12.5 Mylan
- 12.5.1 Mylan Company Details
- 12.5.2 Company Description and Business Overview
- 12.5.3 Substance Use Disorders (SUDs) Treatment Introduction
- 12.5.4 Mylan Revenue in Substance Use Disorders (SUDs) Treatment Business (2014-2019)
- 12.5.5 Mylan Recent Development
- 12.6 Cipla
- 12.6.1 Cipla Company Details
- 12.6.2 Company Description and Business Overview
- 12.6.3 Substance Use Disorders (SUDs) Treatment Introduction
- 12.6.4 Cipla Revenue in Substance Use Disorders (SUDs) Treatment Business (2014-2019)
- 12.6.5 Cipla Recent Development
- 12.7 Glenmark
- 12.7.1 Glenmark Company Details
- 12.7.2 Company Description and Business Overview
- 12.7.3 Substance Use Disorders (SUDs) Treatment Introduction
- 12.7.4 Glenmark Revenue in Substance Use Disorders (SUDs) Treatment Business (2014-2019)
- 12.7.5 Glenmark Recent Development
- 12.8 Dr. Reddy's Laboratories
- 12.8.1 Dr. Reddy's Laboratories Company Details
- 12.8.2 Company Description and Business Overview
- 12.8.3 Substance Use Disorders (SUDs) Treatment Introduction
- 12.8.4 Dr. Reddy's Laboratories Revenue in Substance Use Disorders (SUDs) Treatment Business (2014-2019)
- 12.8.5 Dr. Reddy's Laboratories Recent Development
- 12.9 Teva Pharmaceutical
- 12.9.1 Teva Pharmaceutical Company Details
- 12.9.2 Company Description and Business Overview
- 12.9.3 Substance Use Disorders (SUDs) Treatment Introduction
- 12.9.4 Teva Pharmaceutical Revenue in Substance Use Disorders (SUDs) Treatment Business (2014-2019)
- 12.9.5 Teva Pharmaceutical Recent Development
13 Market Forecast 2019-2025
- 13.1 Market Size Forecast by Regions
- 13.2 United States
- 13.3 Europe
- 13.4 China
- 13.5 Japan
- 13.6 Southeast Asia
- 13.7 India
- 13.8 Central & South America
- 13.9 Market Size Forecast by Product (2019-2025)
- 13.10 Market Size Forecast by Application (2019-2025)
14 Analyst's Viewpoints/Conclusions
15 Appendix
- 15.1 Research Methodology
- 15.1.1 Methodology/Research Approach
- 15.1.1.1 Research Programs/Design
- 15.1.1.2 Market Size Estimation
- 12.1.1.3 Market Breakdown and Data Triangulation
- 15.1.2 Data Source
- 15.1.2.1 Secondary Sources
- 15.1.2.2 Primary Sources
- 15.1.1 Methodology/Research Approach
- 15.2 Disclaimer
Summary:
Get latest Market Research Reports on Substance Use Disorders (SUDs) Treatment . Industry analysis & Market Report on Substance Use Disorders (SUDs) Treatment is a syndicated market report, published as Global Substance Use Disorders (SUDs) Treatment Market Size, Status and Forecast 2019-2025. It is complete Research Study and Industry Analysis of Substance Use Disorders (SUDs) Treatment market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
